Eton Pharmaceuticals Inc (ETON)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Eton Pharmaceuticals Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Eton Pharmaceuticals Inc (ETON) has returned 45.95% so far this year and 90.14% over the past 12 months.

Based on dividend-adjusted daily data since Nov 13, 2018, ETON's average daily return is +0.15%, while the average monthly return is +3.08%. At this rate, your investment would double in approximately 1.9 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2024 with a return of +59.7%, while the worst month was Nov 2021 at -32.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 3 months.

On a daily basis, ETON closed higher 49% of trading days. The best single day was Aug 11, 2023 with a return of +38.1%, while the worst single day was Mar 16, 2020 at -20.5%.

Eton Pharmaceuticals Inc has an annualized alpha of 31.36%, beta of 0.82, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since November 14, 2018.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (85.39%) than losses (49.55%) — typical of diversified or defensive assets.
• R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ETON ranks 81 for risk / return — in the top 81% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Eton Pharmaceuticals Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Eton Pharmaceuticals Inc was 79.94%, occurring on Oct 20, 2022. Recovery took 519 trading sessions.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Eton Pharmaceuticals Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Eton Pharmaceuticals Inc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.